Improving Patient Adherence and Quality of Life in Hereditary Angioedema (HAE): Strategies for
Improving Administration of Treatment and
Managing Adverse Events

A continuing medical education activity sponsored by NAMCP and AAMCN.

New Horizons in the Management of Hereditary Angioedema (HAE): What Managed Care Needs to Know About Novel Therapies in an Evolving Treatment Paradigm is a 3-part live webinar series that will provide attendees with the latest information in the management of Hereditary Angioedema

This is Part 2 of the series focusing on patient adherence and quality of life
in the treatment and management of Hereditary Angioedema

This activity is an archive from the webinar held February 15, 2019.

This activity is valid from March 1, 2019 to March 1, 2020.

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
CSL Behring

Hereditary angioedema (HAE) is a rare autosomal dominant condition characterized by recurrent attacks of edema at different locations of the body. This potentially life-threatening disease affects approximately 1 in 67,000 individuals. HAE is characterized by recurrent edema attacks and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected. Fortunately, novel therapies have recently become available that have shown improved efficacy and safety with improved administration methods. This webinar series will feature strategies to overcome challenges in the optimal long term treatment of HAE, updates on new therapies, and practical managed care approaches to provide cost-effective solutions to improve patient outcomes.

This webinar is part 2 of a 3-part live webinar series on novel therapies in HAE. This webinar will focus on improving patient adherence and quality life in HAE patients with a close look at managing side effects of novel therapies.

Upon completion of this activity, participants will be able to:

  • Examine novel administration methods for novel therapies in Hereditary Angioedema (HAE) and how they are changing the treatment paradigm

  • Identify strategies for anticipating, recognizing, and managing adverse events of novel therapy in patients with HAE

  • Discuss methods to communicate effectively with HAE patients and the multidisciplinary team to understand and address the needs of each patient around C1 Esterase Inhibitors and improve treatment adherence and quality of life

  • Review how treatment strategies can be affected by adverse events based on patient’s individualized needs

Faculty: Jonathan A. Bernstein, M.D.
Professor of Medicine
University of Cincinnati College of Medicine
Department of Internal Medicine
Division of Immunology, Allergy Section


Dr. Bernstein is a consultant for BioCryst, CSL Behring, Kalvista, Pharming Healthcare Inc., and Shire. He has served on an advisory board for BioCryst, CSL Behring, Pharming Healthcare Inc., and Shire. He has received grant/research support from BioCryst, CSL Behring, Pharming Healthcare Inc., and Shire. He is on the speaker’s bureau for CSL Behring, Pharming Healthcare, Inc. and Shire. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
CSL Behring

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue